Evaluating the Minimal Clinically Important Difference of EQ-5D-3L in Patients With Degenerative Lumbar Spinal Stenosis: A Swiss Prospective Multicenter Cohort Study.

MLA

Burgstaller, Jakob M., et al. “Evaluating the Minimal Clinically Important Difference of EQ-5D-3L in Patients With Degenerative Lumbar Spinal Stenosis: A Swiss Prospective Multicenter Cohort Study.” Spine, vol. 45, no. 18, Sept. 2020, pp. 1309–16. EBSCOhost, https://doi.org/10.1097/BRS.0000000000003501.

APA

Burgstaller, J. M., Wertli, M. M., Ulrich, N. H., Pichierri, G., Brunner, F., Farshad, M., Porchet, F., Steurer, J., & Gravestock, I. (2020). Evaluating the Minimal Clinically Important Difference of EQ-5D-3L in Patients With Degenerative Lumbar Spinal Stenosis: A Swiss Prospective Multicenter Cohort Study. Spine, 45(18), 1309–1316. https://doi.org/10.1097/BRS.0000000000003501

Chicago

Burgstaller, Jakob M, Maria M Wertli, Nils H Ulrich, Giuseppe Pichierri, Florian Brunner, Mazda Farshad, François Porchet, Johann Steurer, and Isaac Gravestock. 2020. “Evaluating the Minimal Clinically Important Difference of EQ-5D-3L in Patients With Degenerative Lumbar Spinal Stenosis: A Swiss Prospective Multicenter Cohort Study.” Spine 45 (18): 1309–16. doi:10.1097/BRS.0000000000003501.